A cure for traffic jams:: Small molecule chaperones in the endoplasmic reticulum

被引:50
作者
Römisch, K
机构
[1] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 2XY, England
[2] Dept Clin Biochem, Cambridge CB2 2XY, England
关键词
chemical chaperones; conformational diseases; endoplasmic reticulum; pharmaceutical chaperones; protein degradation; protein folding; protein quality control; protein secretion;
D O I
10.1111/j.1600-0854.2004.00231.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Folding in the endoplasmic reticulum is the limiting step for the biogenesis of most secretory pathway cargo proteins; proteins which fail to fold are initially retained in the endoplasmic reticulum and subsequently often degraded. Mutations that affect secretory protein folding have profound phenotypes irrespective of their direct impact on protein function, because they prevent secretory proteins from reaching their final destination. When unicellular organisms are stressed by fluctuation of temperature or ionic strength, they synthesize high concentrations of small molecules such as trehalose or glycerol to prevent protein denaturation. These osmolytes can also stabilize mutant secretory proteins and allow them to pass secretory protein quality control in the endoplasmic reticulum. Specific ligands and cofactors such as ions, sugars, or peptides have similar effects on specific defective proteins and are beginning to be used as therapeutic agents for protein trafficking diseases.
引用
收藏
页码:815 / 820
页数:6
相关论文
共 57 条
[1]   THE OSMO-INDUCIBLE GPD1(+) GENE IS A TARGET OF THE SIGNALING PATHWAY INVOLVING WIS1 MAP-KINASE KINASE IN FISSION YEAST [J].
AIBA, H ;
YAMADA, H ;
OHMIYA, R ;
MIZUNO, T .
FEBS LETTERS, 1995, 376 (03) :199-201
[2]   The proteasome: a novel target for cancer chemotherapy [J].
Almond, JB ;
Cohen, GM .
LEUKEMIA, 2002, 16 (04) :433-443
[3]   Traffic jams II: An update of diseases of intracellular transport [J].
Aridor, M ;
Hannan, LA .
TRAFFIC, 2002, 3 (11) :781-790
[4]   Traffic jam: A compendium of human diseases that affect intracellular transport processes [J].
Aridor, M ;
Hannan, LA .
TRAFFIC, 2000, 1 (11) :836-851
[5]   Pharmacological chaperones:: potential treatment for conformational diseases [J].
Bernier, V ;
Lagacé, M ;
Bichet, DG ;
Bouvier, M .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2004, 15 (05) :222-228
[6]   Getting newly synthesized proteins into shape [J].
Bukau, B ;
Deuerling, E ;
Pfund, C ;
Craig, EA .
CELL, 2000, 101 (02) :119-122
[7]   Chemical chaperones mediate increased secretion of mutant α1-antitrypsin (α1-AT) Z:: A potential pharmacological strategy for prevention of liver injury and emphysema in α1-AT deficiency [J].
Burrows, JAJ ;
Willis, LK ;
Perlmutter, DH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (04) :1796-1801
[8]  
Cheng AL, 2001, ANTICANCER RES, V21, P2895
[9]  
Davis RL, 1999, NATURE, V401, P376, DOI 10.1038/43897
[10]   PROCESSING OF MUTANT CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR IS TEMPERATURE-SENSITIVE [J].
DENNING, GM ;
ANDERSON, MP ;
AMARA, JF ;
MARSHALL, J ;
SMITH, AE ;
WELSH, MJ .
NATURE, 1992, 358 (6389) :761-764